PubRank

Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN) (ASPIRIN)

Clinical Trial ID NCT02409680

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02409680

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Epidemiology and causes of preterm birth. Lancet 2008 18.96
2 A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005 17.32
3 An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008 8.64
4 The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2009 8.17
5 Prevention of premature birth. N Engl J Med 1998 5.73
6 CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997 5.27
7 Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005 4.57
8 Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Italian study of aspirin in pregnancy. Lancet 1993 3.54
9 Deaths: leading causes for 2001. Natl Vital Stat Rep 2003 3.11
10 CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994 3.08
11 Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial. Lancet 2014 3.05
12 Risk factors for low birth weight: a review. Eur J Obstet Gynecol Reprod Biol 2004 2.86
13 Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 2002 2.74
14 The mechanism of action of aspirin. Thromb Res 2003 2.72
15 Births: preliminary data for 2012. Natl Vital Stat Rep 2013 2.65
16 Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000. Obstet Gynecol 2005 2.29
17 Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003 2.28
18 Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic. Lancet 1999 2.27
19 Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest 1983 2.13
20 Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009 2.10
21 Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007 2.07
22 Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003 2.03
23 Maternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study. Am J Public Health 2006 1.97
24 ACOG committee opinion no. 561: Nonmedically indicated early-term deliveries. Obstet Gynecol 2013 1.82
25 Prediction of pre-eclampsia by abnormal uterine Doppler ultrasound and modification by aspirin. Br J Obstet Gynaecol 1996 1.79
26 Sex differences in platelet reactivity and response to low-dose aspirin therapy. JAMA 2006 1.67
27 Life-table analysis of the risk of perinatal death at term and post term in singleton pregnancies. Am J Obstet Gynecol 2001 1.67
28 Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993 1.64
29 Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia. Am J Obstet Gynecol 2003 1.57
30 High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 2001 1.53
31 Antenatal indomethacin--adverse fetal effects confirmed. Aust N Z J Obstet Gynaecol 1998 1.45
32 Infant mortality statistics from the 2002 period: linked birth/infant death data set. Natl Vital Stat Rep 2004 1.43
33 Individualising use of aspirin to prevent pre-eclampsia: a framework for clinical decision making. BJOG 2003 1.43
34 Physician's health study: aspirin and primary prevention of coronary heart disease. N Engl J Med 1989 1.29
35 Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol 2002 1.27
36 Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002 1.25
37 Minimally invasive comprehensive surgical staging for endometrial cancer: Robotics or laparoscopy? Gynecol Oncol 2009 1.20
38 Premature infants grow up. N Engl J Med 2002 1.20
39 Antiplatelet agents for preventing and treating pre-eclampsia. Cochrane Database Syst Rev 2000 1.10
40 Bacterial lipopolysaccharide-mediated fetal death. Production of a newly recognized form of inducible cyclooxygenase (COX-2) in murine decidua in response to lipopolysaccharide. J Clin Invest 1995 1.08
41 Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler. BJOG 2005 1.07
42 Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention. Best Pract Res Clin Haematol 2006 1.05
43 How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview. BJOG 2000 1.01
44 Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics 1996 0.98
45 Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition. J Clin Invest 2005 0.98
46 Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study. Am J Obstet Gynecol 2005 0.97
47 Risk factors for preterm birth in Korea: a multicenter prospective study. Gynecol Obstet Invest 2005 0.93
48 Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2004 0.93
49 Venous Doppler in the prediction of acid-base status of growth-restricted fetuses with elevated placental blood flow resistance. Am J Obstet Gynecol 2004 0.88
50 Tocolytic therapy for acute preterm labor. Obstet Gynecol Clin North Am 2012 0.88
51 Preeclampsia prevention: lessons from the low-dose aspirin therapy trials. Am J Obstet Gynecol 2000 0.88
52 Prenatal low-dose aspirin and neurobehavioral outcomes of children born very preterm. Pediatrics 2009 0.87
53 Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial. Croat Med J 2005 0.87
54 Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol 2005 0.85
55 Low dose aspirin for the treatment of fetal growth restriction: a randomized controlled trial. Aust N Z J Obstet Gynaecol 1995 0.83
56 Screening with a uterine Doppler in low risk pregnant women followed by low dose aspirin in women with abnormal results: a multicenter randomised controlled trial. BJOG 2001 0.82
57 Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Régional Aspirine Mère-Enfant study (Part 2). BJOG 2003 0.82
58 Perinatal vasoconstrictive renal insufficiency associated with maternal nimesulide use. Am J Perinatol 1999 0.80
59 A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow. Obstet Gynecol 1996 0.79
60 Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders. Acta Obstet Gynecol Scand 2004 0.78
61 Antiprostaglandin drugs. Obstet Gynecol Clin North Am 2005 0.75
Next 100